ArticleHealth equity2021
Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index.
Article in Health equity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Inequality in the distribution of Covid-19 vaccine: a systematic review.International journal for equity in health · 2022Pooled it
- Inequity in the use of long-lasting insecticidal nets before and after nationwide mass distribution campaign in 48 districts of Uganda: VERSE toolkit analysis.BMC public health · 2025Article
- Identifying Areas with Low Access to the COVID-19 Vaccine: A New Objective Framework Incorporating Mobility Data.Healthcare (Basel, Switzerland) · 2025Article
- A Global Index to Quantify Discrimination Resulting from COVID-19 Pandemic Response Policies.International journal of environmental research and public health · 2025Article
- Article
- Creating the vaccination improvement potential index.Heliyon · 2024Article
- COVID-19 vaccine coverage, determinants and inequity amongst refugees and migrants in Pakistan: a cross-sectional study.BMJ open · 2024Article
- Advances in nanobiosensors during the COVID-19 pandemic and future perspectives for the post-COVID era.Nano convergence · 2024Review
- Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.PloS one · 2024Article
- Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile.Health equity · 2024Article
- Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer.Journal of the National Cancer Institute · 2023Article
- COVID-19 vaccine equity in doldrums: Good governance deficits.Public administration and development : a journal of the Royal Institute of Public Administration · 2022Article
- Sequential allocation of vaccine to control an infectious disease.Mathematical biosciences · 2022Article
- A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) project.Social science & medicine (1982) · 2022Article
- COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.